Sort
51,593 grants matching “hepatitis”
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery
$640,842Ramasamy Paulmurugan · Stanford University · R01 · FY2018 · CA
UNDERSTANDING HEPATIC PROTEOSTASIS IN SYSTEMIC AMYLOID DISEASES
$640,815Rockland L Wiseman · Scripps Research Institute, The · R01 · FY2023 · DK
Targeting Acid Ceramidase for Hepatic Fibrogenesis
$640,808Hyunil Jo · University Of California, San Francisco · R01 · FY2024 · DK
Acute HCV Infection in Injection Drug Users
$640,563Weill Medical College Of Cornell Univ · R01 · FY2004 · DA
Erythroblastic Island Macrophages in SCD Disordered Erythropoiesis.
$640,500Xiuli An · New York Blood Center · P01 · FY2025 · HL
Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States
$640,348Magdalena Cerda · New York University School Of Medicine · R01 · FY2024 · DA
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations
$640,328Keoki Williams · Henry Ford Health System · R01 · FY2019 · DK
Understanding the Multilevel Drivers of Liver Cancer Disparities
$640,322Salma Shariff-Marco · University Of California, San Francisco · R01 · FY2022 · CA
Phase II trial of tesamorelin for cognition in aging HIV-infected persons
$640,315Ronald J. Ellis · University Of California, San Diego · R01 · FY2018 · AG
Modeling Epidemic Infectious Diseases Using Sequence Analysis
$640,128Sergei L Kosakovsky Pond · University Of California, San Diego · U01 · FY2014 · GM
Phase I/II Trials of Silymarin for Chronic Liver Diseases Data Coordinating Cente
$640,096Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · AT
Phase II trial of tesamorelin for cognition in aging HIV-infected persons
$640,095Ronald J. Ellis · University Of California, San Diego · R01 · FY2017 · AG
The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans
$640,079Christopher Keith Haddock · Ndri-Usa, Inc. · R01 · FY2024 · DA
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA
$640,054Ivan Pedrosa · Ut Southwestern Medical Center · R01 · FY2022 · CA
Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population Control
$640,009Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2024 · HD
Brief Intervention for Drug Misuse for the Emergency Department (BIDMED)
$640,002Roland C Merchant · Rhode Island Hospital · R01 · FY2009 · DA
Obesity risk in African American women is determined by a diet-by-phenotype interaction
$639,953Barbara A. Gower · University Of Alabama At Birmingham · R01 · FY2021 · DK
Repurposing and reformulation of adefovir dipivoxil for improved topical treatment of herpes simplex virus infection of the eye
$639,940Abhijit A Date · University Of Arizona · R01 · FY2025 · EY
Developmental of a PAL PKU Enzyme Substitution Therapy
$639,851Raymond C Stevens · Scripps Research Institute, The · U01 · FY2008 · NS
Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States
$639,776Meira Epplein · Duke University · R01 · FY2025 · CA
CCR FACS Core Laboratory
$639,679Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Multiepitope circumsporozoite P.falciparum malaria subunit vaccine displayed on v
$639,675David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2012 · AI
Gigapixel digital PCR in Giant Unilamellar Vesicles
$639,634Adam R. Abate · University Of California, San Francisco · R01 · FY2019 · EB
Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease
$639,629Marialena Mouzaki · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · DK
Hepatitis C Pathogenesis &The Human Genome
$639,615Johns Hopkins University · R01 · FY2004 · DA